Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mulvanny (Manchester, United Kingdom), N. Jackson (Manchester, United Kingdom), C. Pattwell (Manchester, United Kingdom), S. Wolosianka (Manchester, United Kingdom), T. Southworth (Manchester, United Kingdom), D. Singh (Manchester, United Kingdom). Inhaled LPS challenge in healthy subjects: a dose escalation study. 4405

Member's Comments

No comment yet.

Related content which might interest you: Dose escalation study in healthy male subjects to investigate safety, tolerability and systemic exposure of orally inhaled single-doses of AP301 Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Late Breaking Abstract - Phase 1 dose escalation study of aerosolized pirfenidone in normal healthy volunteers (NHV), smokers, and IPF patients Source: International Congress 2018 – ILDs: From bench to bedside Year: 2018 Inhaled steroids doses to obtain asthma control in children: a randomised concurrent cohort study Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009 The failure rate of sputum induction following inhaled lipopolysaccharide (LPS) challenge in healthy subjects Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Reproducebility and safety of endotoxin inhalation in healthy subjects Source: Eur Respir J 2004; 24: Suppl. 48, 444s Year: 2004 Acute asthma treatment: comparison of formoterol and salbutamol given in cumulative doses in children Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001 Salmeterol pharmacokinetics following a 50-mcg dose by dry powder oral inhalation to healthy volunteers Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 High doses of inhaled formoterol have less systemic effect in asthmatic children than high doses of inhaled terbutaline Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003 Treatment of patients with uncontrolled asthma using high dose inhaled corticosteroids administered by controlled inhalation – a retrospective analysis Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Efficacy of high dose inhaled DSCG on asthma control in young children Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008 The effect of single dose inhaled budesonide on Amppc20 in patients with mild asthma: a 3 month follow up Source: Eur Respir J 2005; 26: Suppl. 49, 369s Year: 2005 Effect of a single dose of formoterol and tiotropium in exercise tolerance in COPD patients: preliminary data Source: Eur Respir J 2003; 22: Suppl. 45, 405s Year: 2003 Tolerance to the protective effect of salmeterol+fluticasone combination (50/250 mcg) on allergen challenge in mild untreated asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 388s Year: 2002 Inhaled ciclesonide is well-tolerated in children with persistent asthma: results from the rainbow study Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Tolerance to the protective effect of salmeterol on allergen challenge in mild untreated asthmatics and in moderate asthmatics on inhaled corticosteroid treatment Source: Eur Respir J 2001; 18: Suppl. 33, 103s Year: 2001 Relationships of mannitol challenge to methacholine challenge and inflammatory markers in asthmatics receiving inhaled corticosteroids Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Low systemic exposure of NVA237, an inhaled once-daily anticholinergic bronchodilator, in healthy humans Source: Eur Respir J 2006; 28: Suppl. 50, 661s Year: 2006 Safety, pharmacokinetics, and pharmacodynamics of TD-8236, an inhaled pan-JAK inhibitor, following single- and multiple-ascending doses in healthy volunteers and mild asthmatics Source: Virtual Congress 2021 – Clinical trials in airway diseases: novel treatments and new evidence Year: 2021